Wealthcare Advisory Partners’s VivoSim Labs VIVS Stock Holding History

Wealthcare Advisory Partners’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-67	Closed	-$8K	–	1943
2021 Q1	$8K	Buy	+67	New	+$10.5K	﹤0.01%	1539
2020 Q3	–	Sell	-67	Closed	-$9K	–	373
2020 Q2	$9K	Hold	67	–	–	﹤0.01%	320
2020 Q1	$7K	Hold	67	–	–	﹤0.01%	1030
2019 Q4	$6K	Hold	67	–	–	﹤0.01%	1082
2019 Q3	$4K	Sell	67 -20	-23%	-$1.68K	﹤0.01%	1122
2019 Q2	$11K	Buy	87 +10	+13%	+$1.89K	﹤0.01%	889
2019 Q1	$18K	Buy	77 +21	+38%	+$5.29K	﹤0.01%	692
2018 Q4	$13K	Sell	56 -11	-16%	-$2.77K	﹤0.01%	738
2018 Q3	$18K	Buy	67 +3	+5%	+$902	﹤0.01%	714
2018 Q2	$21K	Buy	64 +33	+106%	+$10.9K	﹤0.01%	666
2018 Q1	$8K	Hold	31	–	–	﹤0.01%	781
2017 Q4	$10K	Sell	31 -4	-11%	-$1.49K	﹤0.01%	686
2017 Q3	$19K	Buy	+35	New	+$18.6K	0.01%	442

Other funds holding VIVS

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wealthcare Advisory Partners's VIVS Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of VivoSim Labs (VIVS) in Q2 2021, closing a stake of 67 shares — an estimated $8K sold.

Wealthcare Advisory Partners first reported a position in VIVS in Q3 2017 and held it in 13 quarters. The position peaked at $21K in Q2 2018. 50 funds tracked by Wall St. Rank hold VIVS as of Q2 2021.

Wealthcare Advisory Partners reported no remaining VivoSim Labs position as of Q2 2021 after selling out during the quarter.
Wealthcare Advisory Partners sold 67 VivoSim Labs shares in Q2 2021, an estimated $8K.
Wealthcare Advisory Partners first reported a position in VivoSim Labs in Q3 2017 and held it in 13 quarters.
Wealthcare Advisory Partners's VivoSim Labs position peaked at $21K in Q2 2018.
50 funds tracked by Wall St. Rank held VivoSim Labs as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.